Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications
- 457 Downloads
A series of hexa-coordinated ruthenium(II) complexes of the type [Ru(CO)(B)L n ] (n = 1–4; B = PPh3, AsPh3 or Py) have been synthesized by reacting dibasic quadridentate Schiff base ligands H2L n (n = 1–4) with starting complexes [RuHCl(CO)(EPh3)2(B)] (E = P or As; B = PPh3, AsPh3 or Py). The synthesized complexes were characterized using elemental and various spectral studies including UV–Vis, FT-IR, NMR (1H, 13C and 31P) and mass spectroscopy. An octahedral geometry was tentatively proposed for all the complexes based on the spectral data obtained. The experiments on antioxidant activity showed that the ruthenium(II) S-methylisothiosemicarbazone Schiff base complexes exhibited good scavenging activity against various free radicals (DPPH, OH and NO). The in vitro cytotoxicity of these complexes has been evaluated by MTT assay. The results demonstrate that the complexes have good anticancer activities against selected cancer cell line, human breast cancer cell line (MCF-7) and human skin carcinoma cell line (A431). The DNA cleavage studies showed that the complexes have better cleavage of pBR 322 DNA.
KeywordsRuthenium(II) complexes Spectral studies Antioxidant Anticancer activity DNA cleavage
We are thankful to the IISC Bangalore, STIC Cochin, SAIF Panjab University, Chandigarh for providing instrumental facilities. We also thankful to KMCH, Coimbatore and Biogenics Research and training center in Biotechnology, Hubli, Karnataka for anticancer and DNA cleavage studies.
- Beckford FA, Leblanc G, Thessing J, Shaloski M, Frost BJ, Li L, Seeram NP (2009) Organometallic ruthenium complexes with thiosemicarbazone ligands: Synthesis, structure and cytotoxicity of [(η6-p-cymene)Ru(NS)Cl]+ (NS = 9-anthraldehyde thiosemicarbazones). Inorg Chem Commun 12:1094–1098PubMedCrossRefGoogle Scholar
- Da S, Maia PI, Pavan FR, Leite CQF, Lemos SS, de Sousa GF, Batista AA, Nascimento OR, Ellena J, Castellano EE, Niquet E, Deflon VM (2009) Vanadium complexes with thiosemicarbazones: synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity. Polyhedron 28:398–406CrossRefGoogle Scholar
- Demoro B, Sarniguet C, Sanchez-Delgado R, Rossi M, Liebowitz D, Caruso F, Olea-Azar C, Moreno V, Medeiros A, Comini MA, Otero L, Gambino D (2012) New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents. Dalton Trans 41(5):1534–1543PubMedCrossRefGoogle Scholar
- Jouad EM, Thanh XD, Bouet G, Bonneau S, Khan MA (2002) In vitro and in vivo effects of [Ni(M5FTSC)2C12] complex in cancer: preliminary tests. Anticancer Res 22:1713Google Scholar
- Kalaivani P, Prabhakaran R, Poornima P, Dallemer F, Vijayalakshmi K, Vijaya Padma V, Natarajan K (2012) Versatile coordination behavior of salicylaldehyde thiosemicarbazone in ruthenium(II) carbonyl complexes: synthesis, spectral, X-ray, electrochemistry, DNA binding, cytotoxicity, and cellular uptake Studies. Organometallics 31:8323–8332CrossRefGoogle Scholar
- Ramachandran E, Thomas SP, Poornima P, Kalaivani P, Prabhakaran R, Vijaya Padma V, Natarajan K (2012) Evaluation of DNA binding, antioxidant and cytotoxic activity of mononuclear Co(III) complexes of 2-oxo-1,2-dihydrobenzo[h]quinoline-3-carbaldehyde thiosemicarbazones. Eur J Med Chem 50:405–415PubMedCrossRefGoogle Scholar
- Sathiya Kamatchi T, Chitrapriya N, Lee H, Fronczek CF, Fronczek FR, Natarajan K (2012) Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro. Dalton Trans 41:2066–2077CrossRefGoogle Scholar
- Sathyadevi P, Krishnamoorthy P, Bhuvanesh SP, Kalaiselvi P, Vijaya Padma V, Dharmaraj N (2012) Organometallic ruthenium(II) complexes: Synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity. Eur J Med Chem 55:420–431PubMedCrossRefGoogle Scholar